Results 71 to 80 of about 2,707 (196)

Detection of Alpha-Methylacyl-CoA Racemase (AMACR), a Biomarker of Prostate Cancer, in Patient Blood Samples Using a Nanoparticle Electrochemical Biosensor

Biosensors, 2012
Although still commonly used in clinical practice to screen and diagnose prostate cancer, there are numerous weaknesses of prostate-specific antigen (PSA) testing, including lack of specificity and the inability to distinguish between aggressive and ...
Chung Chiun Liu, Cheryl L. Thompson, Sanjay Gupta, Matthew Cooney, Anna C. Samia, Fuh-Sheng Shieu, Kai-Lun Cheng, James D. McGuffin-Cawley, Po-Yuan Lin   +8 more
doaj   +1 more source

Prostatic adenocarcinoma with a peculiar morphology – a rare case of pseudohyperplastic variant with inverted polarity

Surgical and Experimental Pathology, 2022
Background The inverted (hobnail) variant of high-grade prostatic intraepithelial neoplasia (HGPIN) has been reported in two previous series and one case of inverted polarity in invasive adenocarcinoma has been reported. We reported an additional case of
Daniel Abensur Athanazio, Maiara Ferreira de Souza, Maria Estela Pompeu do Amaral   +2 more
doaj   +1 more source

Hot issues on Chinese expert consensus of prostate cancer management

UroPrecision, Volume 2, Issue 4, Page 163-179, December 2024.
Abstract Prostate cancer is one of the most common solid tumors in men, and its incidence continues to rise in China. Several guidelines have been developed and published to facilitate the standardization of diagnosis and treatment of prostate cancer. However, there are still many challenges and issues in clinical practice that lack high‐level evidence.
Sujun Han, Xinan Sheng, Xiaojian Qin, Peng Wu, Zhonghua Yang, Hao Zeng, Hao Liu, Baojun Wang, Zhien Zhou, Gang Song, Dingwei Ye, Weijun Qin, Xinghuan Wang, Qiang Wei, Jian Huang, Tianxin Lin, Xu Zhang, Zhigang Ji, Nianzeng Xing   +18 more
wiley   +1 more source

Evaluation of a short RNA within Prostate Cancer Gene 3 in the predictive role for future cancer using non-malignant prostate biopsies. [PDF]

, 2017
BACKGROUND: Prostate Cancer 3 (PCA3) is a long non-coding RNA (ncRNA) upregulated in prostate cancer (PCa). We recently identified a short ncRNA expressed from intron 1 of PCA3.
A. Aakula, A. Haese, A. Paziewska, A.A. Svoronos, B. Djavan, D. Hessels, D.J. Rosario, Derek J. Rosario, F.H. Schroder, G. Gandaglia, J. Klecka, J.B. de Kok, J.W. Catto, James W. F. Catto, Karl H. Pang, L.P. Bokhorst, M. Herawi, M. Salagierski, M.J. Bussemakers, M.M. Vedder, Mohammad Saleem, N. Mottet, R.A. Clarke, R.M. Drayton, S. Alinezhad, S. Miah, S.A. Tomlins, Susan L. Morgan   +27 more
core   +2 more sources

Prostatic duct adenocarcinoma—A challenging variant of prostate cancer in a low‐resource setting

Clinical Case Reports, Volume 12, Issue 11, November 2024.
Key Clinical Message This case emphasizes the challenges in diagnosing and treating Prostatic Duct Adenocarcinoma, especially in resource‐limited settings. Early and accurate diagnosis is crucial for better patient outcomes, but limited access to advanced diagnostics and specialized treatments significantly hinders the effective management of this ...
Ronald Okidi, Nakazibwe Hajarah, Derrick Mukurasi, Emmanuel Obonyo, Emmanuel Makai, Daniel Lajul, Moses Odongkara, Tracy Bamutorana, BridgetRose Aguti Omagino, Isaac Okello   +9 more
wiley   +1 more source

Investigation of the incidence of latent prostate cancer and high-grade prostatic intraepithelial neoplasia in an autopsy series of Turkish males

Urology Research and Practice, 2019
Objective: Epidemiological studies have shown that the incidence of latent prostate cancer differs significantly depending on ethnicity and geographical locations.
Kadir Polat, Emre Tüzel, Fatma Aktepe, Bülent Akdoğan, Cem Güler, İbrahim Uzun   +5 more
doaj   +2 more sources

Risk of prostate cancer associated with benign prostate disease:a primary care case-control study [PDF]

, 2011
BACKGROUND: Benign diseases of the prostate are common in the general male population, and prostate cancer is the most common cancer in men. Uncertaintyastothe nature of the association between benign and malignant disease is a source of concern for ...
Buckley, Brian S, Lapitan, Marie Carmela M, Sheikh, Aziz, Simpson, Colin R   +3 more
core   +2 more sources

Clinical and histopathological parameters in transrectal ultrasound‐guided biopsies associated with tumor upgrading after radical prostatectomy: A comparative analysis of risk groups

The Prostate, Volume 84, Issue 12, Page 1146-1156, September 2024.
Abstract Background Thanks to technological advances, prostate cancer (PCa) can be diagnosed at a younger age. It is known that most of these patients are in the low‐intermediate risk group, and the histological grade of the tumor increases in half of those undergoing radical prostatectomy (Rp) compared to their diagnostic biopsies.
Mustafa Ozkaya, Muhammed Fatih Simsekoglu, Goktug Kalender, Kadir Can Sahin, Iclal Gurses   +4 more
wiley   +1 more source

KI-67 IMMUNOHISTOHEMICAL EXPRESSION IN PROSTATIC LESIONS

The Iraqi Journal of Medical Sciences, 2017
Background: The cell proliferation marker, ki-67, is a nuclear and nucleolar protein, which can be detected during all active phases of the cell cycle (G1, S, G2, and mitosis), but absent from cell resting phases.
Inas A. Rasheed, Alaa G. Hussein, Mohanad M. AbdulGhany   +2 more
doaj   +6 more sources

A universal assay for detection of oncogenic fusion transcripts by oligo microarray analysis [PDF]

, 2009
Background The ability to detect neoplasia-specific fusion genes is important not only in cancer research, but also increasingly in clinical settings to ensure that correct diagnosis is made and the optimal treatment is chosen.
Skotheim, Rolf I, Thomassen, Gard O, Eken, Marthe, Lind, Guro E, Micci, Francesca, Ribeiro, Franclim R, Cerveira, Nuno, Teixeira, Manuel R, Heim, Sverre, Rognes, Torbjørn, Lothe, Ragnhild A   +10 more
core   +2 more sources